Patterns of ecstasy use in Australia: findings from a national household survey
- PMID: 14756711
- DOI: 10.1111/j.1360-0443.2003.00622.x
Patterns of ecstasy use in Australia: findings from a national household survey
Abstract
Aim: To examine the patterns, correlates and context of 'recent' (preceding 12 months) ecstasy use using data from a nationally representative sample of Australians interviewed in 2001.
Design: Data were analysed from the 2001 National Drug Strategy Household Survey, a multi-stage probability sample of Australians aged 14 years or older. The focus was on ecstasy use among 14-19-year-olds and 20-29-year-olds, as the prevalence of recent use is highest among these groups. Recent ecstasy users were compared to those who had not used in the preceding 12 months and those who had never tried ecstasy ('others') on a range of demographic and drug use variables. Comparisons were also drawn between the patterns and context of ecstasy use of the two groups of recent ecstasy users (users aged between 14-19 and 20-29 years).
Findings: In 2001, 6.1% of Australians aged 14 years or older reported life-time ecstasy use, and 2.9% reported recent use. One in 10 (10.4%) of 20-29-year-olds and 5.0% of 14-19-year-olds had used ecstasy recently. Although there were few demographic differences between recent users and others, compared to those who had not recently used ecstasy, recent ecstasy users were more likely to have used a range of other drugs. Although recent ecstasy users of both age groups could be characterized as polydrug users, 20-29-year-old users were more likely to use other drugs concurrently with ecstasy.
Conclusions: Following cannabis and amphetamines, ecstasy is the third most widely used illicit drug in Australia. Other than a greater likelihood of having used other drugs, few demographic variables appear to distinguish recent ecstasy users from others. Australian users in their 20s use ecstasy within a context of greater polydrug use than those in their teens. Although most ecstasy users described a pattern of occasional use, minorities reported weekly use, and difficulties in reducing their use despite wishing to do so. There is a need to develop interventions to assist problematic ecstasy users to reduce their use should they wish to do so and to increase education about the potential risks of combining ecstasy with other drugs.
Similar articles
-
The external validity of results derived from ecstasy users recruited using purposive sampling strategies.Drug Alcohol Depend. 2004 Jan 7;73(1):33-40. doi: 10.1016/j.drugalcdep.2003.09.001. Drug Alcohol Depend. 2004. PMID: 14687957
-
Correlates of Ecstasy use in middle age and beyond.Drug Alcohol Rev. 2005 Jan;24(1):33-8. doi: 10.1080/09595230500124925. Drug Alcohol Rev. 2005. PMID: 16191719
-
Mental disorders in ecstasy users: a prospective-longitudinal investigation.Drug Alcohol Depend. 2002 Oct 1;68(2):195-207. doi: 10.1016/s0376-8716(02)00190-4. Drug Alcohol Depend. 2002. PMID: 12234649
-
Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.J Psychopharmacol. 2006 Mar;20(2):211-25. doi: 10.1177/0269881106059486. J Psychopharmacol. 2006. PMID: 16510479 Review.
-
Recent trends in the use of "club drugs": an Australian review.Subst Use Misuse. 2005;40(9-10):1241-56. doi: 10.1081/JA-200066777. Subst Use Misuse. 2005. PMID: 16048815 Review.
Cited by
-
Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.Subst Use Misuse. 2017 Jan 2;52(1):82-91. doi: 10.1080/10826084.2016.1219373. Epub 2016 Sep 23. Subst Use Misuse. 2017. PMID: 27661470 Free PMC article.
-
N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.Pharmacol Biochem Behav. 2009 Mar;92(1):105-10. doi: 10.1016/j.pbb.2008.10.022. Epub 2008 Nov 13. Pharmacol Biochem Behav. 2009. PMID: 19032963 Free PMC article.
-
The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning.Psychopharmacology (Berl). 2012 Apr;220(4):799-807. doi: 10.1007/s00213-011-2532-9. Epub 2011 Oct 22. Psychopharmacology (Berl). 2012. PMID: 22020992 Clinical Trial.
-
Exploring practice of Isfahan University of Medical Science students regarding using ecstasy based on health belief model in 2011.J Educ Health Promot. 2012;1:32. doi: 10.4103/2277-9531.100162. Epub 2012 Aug 27. J Educ Health Promot. 2012. PMID: 23555135 Free PMC article.
-
Repeated administration of the 5-HT₁B/₁A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT₁A and 5-HT₁B receptor mechanisms.Psychopharmacology (Berl). 2016 Apr;233(8):1339-47. doi: 10.1007/s00213-016-4225-x. Epub 2016 Feb 9. Psychopharmacology (Berl). 2016. PMID: 26856853
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical